Local vaccine producer Medigen says it has officially applied to conduct
Phase 3 clinical trials of its coronavirus vaccine in Paraguay.

Medigen's vaccine completed Phase 2 trials early last month and has since
applied for emergency use authorization here in Taiwan.

The company says it filed the request to conduct Phase 3 clinical trials with
Paraguay's National Health Surveillance Authority earlier this week.

The Phase 3 clinical trials will be conducted in cooperation with the Faculty
of Medical Sciences at the National University of Asuncion.

And Medigen says the test will be carried out through immunobridging to
compare the vaccine's overall level of protection with that of the
AstraZeneca vaccine.

Medigen has not provided a timetable for completion of the Phase 3 clinical
trial in Paraguay.

According to the company, it is also in talks with other international health
regulatory authorities and is planning to conduct more Phase 3 clinical
trials in other countries.